Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report.

Bibliographic Details
Title: Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report.
Authors: Matbouli, Rafik1 (AUTHOR), Pantet, Olivier2 (AUTHOR), Castioni, Julien3 (AUTHOR), Vakilzadeh, Nima4 (AUTHOR), Alberio, Lorenzo5 (AUTHOR), Hugli, Olivier1 (AUTHOR) olivier.hugli@chuv.ch
Source: International Journal of Emergency Medicine. 7/17/2024, Vol. 17 Issue 1, p1-5. 5p.
Subject Terms: *HEMORRHAGE risk factors, *HEMORRHAGE prevention, *ANTICOAGULANTS, *BACTERIAL meningitis, *ACUTE kidney failure, *HEMODIALYSIS, *BENZIMIDAZOLES, *PYRIDINE, *ATRIAL fibrillation, *DRUG efficacy, *DISEASE complications
Abstract: Dabigatran is an oral anticoagulant that is mainly renally excreted. Despite its efficacy in preventing thromboembolic events, concerns arise regarding bleeding complications in patients with acute kidney injury. Idarucizumab is its specific antidote and reverses quickly and effectively dabigatran anticoagulation effects in situations of severe bleeding or pending surgical procedures, but its benefit beyond these two indications remains uncertain. We present a case of a woman with atrial fibrillation anticoagulated by dabigatran and admitted with Streptococcus agalactiae meningitis, acute kidney injury and dabigatran accumulation. Idarucizumab was not administered initially as she did not meet its current strict indications. However, subsequently, significant bleeding necessitated its use. A rebound increase in dabigatran concentration was associated with an intracranial hemorrhage, but the combination of additional doses of idarucizumab with hemodialysis lowered the dabigatran concentration and prevented significant rebound increases. Further investigation into the optimal management of dabigatran accumulation and acute kidney injury-associated bleeding is needed to enhance patient outcomes and safety. Early initiation of hemodialysis together with idarucizumab administration may be crucial in preventing life-threatening bleeding events in these patients. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Emergency Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=18651372&ISBN=&volume=17&issue=1&date=20240717&spage=1&pages=1-5&title=International Journal of Emergency Medicine&atitle=Dabigatran%20accumulation%20in%20acute%20kidney%20injury%3A%20is%20more%20better%20than%20less%20to%20prevent%20bleeding%3F%20A%20case%20report.&aulast=Matbouli%2C%20Rafik&id=DOI:10.1186/s12245-024-00677-3
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 178483107
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Matbouli%2C+Rafik%22">Matbouli, Rafik</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pantet%2C+Olivier%22">Pantet, Olivier</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Castioni%2C+Julien%22">Castioni, Julien</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vakilzadeh%2C+Nima%22">Vakilzadeh, Nima</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alberio%2C+Lorenzo%22">Alberio, Lorenzo</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hugli%2C+Olivier%22">Hugli, Olivier</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> olivier.hugli@chuv.ch</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Emergency+Medicine%22">International Journal of Emergency Medicine</searchLink>. 7/17/2024, Vol. 17 Issue 1, p1-5. 5p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22HEMORRHAGE+risk+factors%22">HEMORRHAGE risk factors</searchLink><br />*<searchLink fieldCode="DE" term="%22HEMORRHAGE+prevention%22">HEMORRHAGE prevention</searchLink><br />*<searchLink fieldCode="DE" term="%22ANTICOAGULANTS%22">ANTICOAGULANTS</searchLink><br />*<searchLink fieldCode="DE" term="%22BACTERIAL+meningitis%22">BACTERIAL meningitis</searchLink><br />*<searchLink fieldCode="DE" term="%22ACUTE+kidney+failure%22">ACUTE kidney failure</searchLink><br />*<searchLink fieldCode="DE" term="%22HEMODIALYSIS%22">HEMODIALYSIS</searchLink><br />*<searchLink fieldCode="DE" term="%22BENZIMIDAZOLES%22">BENZIMIDAZOLES</searchLink><br />*<searchLink fieldCode="DE" term="%22PYRIDINE%22">PYRIDINE</searchLink><br />*<searchLink fieldCode="DE" term="%22ATRIAL+fibrillation%22">ATRIAL fibrillation</searchLink><br />*<searchLink fieldCode="DE" term="%22DRUG+efficacy%22">DRUG efficacy</searchLink><br />*<searchLink fieldCode="DE" term="%22DISEASE+complications%22">DISEASE complications</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Dabigatran is an oral anticoagulant that is mainly renally excreted. Despite its efficacy in preventing thromboembolic events, concerns arise regarding bleeding complications in patients with acute kidney injury. Idarucizumab is its specific antidote and reverses quickly and effectively dabigatran anticoagulation effects in situations of severe bleeding or pending surgical procedures, but its benefit beyond these two indications remains uncertain. We present a case of a woman with atrial fibrillation anticoagulated by dabigatran and admitted with Streptococcus agalactiae meningitis, acute kidney injury and dabigatran accumulation. Idarucizumab was not administered initially as she did not meet its current strict indications. However, subsequently, significant bleeding necessitated its use. A rebound increase in dabigatran concentration was associated with an intracranial hemorrhage, but the combination of additional doses of idarucizumab with hemodialysis lowered the dabigatran concentration and prevented significant rebound increases. Further investigation into the optimal management of dabigatran accumulation and acute kidney injury-associated bleeding is needed to enhance patient outcomes and safety. Early initiation of hemodialysis together with idarucizumab administration may be crucial in preventing life-threatening bleeding events in these patients. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of International Journal of Emergency Medicine is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=178483107
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12245-024-00677-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 1
    Subjects:
      – SubjectFull: HEMORRHAGE risk factors
        Type: general
      – SubjectFull: HEMORRHAGE prevention
        Type: general
      – SubjectFull: ANTICOAGULANTS
        Type: general
      – SubjectFull: BACTERIAL meningitis
        Type: general
      – SubjectFull: ACUTE kidney failure
        Type: general
      – SubjectFull: HEMODIALYSIS
        Type: general
      – SubjectFull: BENZIMIDAZOLES
        Type: general
      – SubjectFull: PYRIDINE
        Type: general
      – SubjectFull: ATRIAL fibrillation
        Type: general
      – SubjectFull: DRUG efficacy
        Type: general
      – SubjectFull: DISEASE complications
        Type: general
    Titles:
      – TitleFull: Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matbouli, Rafik
      – PersonEntity:
          Name:
            NameFull: Pantet, Olivier
      – PersonEntity:
          Name:
            NameFull: Castioni, Julien
      – PersonEntity:
          Name:
            NameFull: Vakilzadeh, Nima
      – PersonEntity:
          Name:
            NameFull: Alberio, Lorenzo
      – PersonEntity:
          Name:
            NameFull: Hugli, Olivier
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 07
              Text: 7/17/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 18651372
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: International Journal of Emergency Medicine
              Type: main
ResultId 1